Advanced Search

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    FUSN A Fusion Pharmaceuticals Inc. 0.00
    ARAY A Accuray Incorporated -2.71
    ACLX A Arcellx, Inc. 0.93
    VINC A Vincera Pharma, Inc. 3.14
    VERS A ProShares Metaverse ETF 0.00
    CARM A Carisma Therapeutics, Inc. 0.35
    INAB A IN8bio, Inc. 2.96
    MRUS A Merus N.V. 4.83
    KURA A Kura Oncology, Inc. 1.69
    IOVA A Iovance Biotherapeutics, Inc. 2.52
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices
    Related Stock Lists: Cancer Medicine Biopharmaceutical Clinical Medicine Leukemia Multiple Myeloma Oncology Acute Myeloid Leukemia Advanced Solid Tumors Biotechnology Blastoma Cancer Treatment Cell Therapy Glioblastoma Immune System Immunology Pharmaceutical Targeted Therapy Treatment Of Cancer Antineoplastic Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR B Loncar Cancer Immunotherapy ETF 15.5
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 4.2
    XBI B SPDR S&P Biotech ETF 2.39
    IDNA B iShares Genomics Immunology and Healthcare ETF 2.3
    SBIO B ALPS Medical Breakthroughs ETF 2.19
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to IDNA Compare IDNA to SBIO Compare XBI to SBIO

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 31 FUSN Fusion Pharmaceuticals to Present at the Jefferies Healthcare Conference
        May 31 FUSN These 2 “Strong Buy” Penny Stocks Could Surge 200% (or More), Says Wedbush
        May 31 CARM Carisma spikes as Jefferies issues Buy citing lead asset
        May 31 MRUS Merus to Participate in a Fireside Chat at the Jefferies Healthcare Conference 2023
        May 31 IOVA Iovance: Hard To Resist This Historic Solid Tumor Cell Therapy Approval Shot
        May 30 CARM Carisma Therapeutics to Present at Upcoming Healthcare Industry Conferences in June 2023
        May 30 IOVA Why Shares of Iovance Biotherapeutics Jumped Tuesday
        May 30 IOVA Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
        May 30 IOVA Iovance rises as Wall Street reacts to FDA priority review for melanoma drug
        May 30 KURA Kura Oncology Announces Late-Breaking Abstract Accepted for Oral Presentation at the 2023 European Hematology Association (EHA) Congress
        May 30 IOVA These Stocks Are Moving the Most Today: Nvidia, C3.ai, Palantir, Nutanix, Iovance Biotherapeutics, and More
        May 29 IOVA FDA Accepts Iovance's (IOVA) BLA Filing for Melanoma Drug
        May 26 IOVA Iovance up 15% on FDA acceptance of lifileucel application for melanoma
        May 26 IOVA Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices
        Related Stock Lists: Medicine Cancer Clinical Medicine Biopharmaceutical Myelodysplastic Syndrome Acute Leukemia Acute Myeloid Leukemia Antibodies Biotechnology Cancer Immunotherapy Cell Therapy Checkpoint Inhibitor Immune System Leukemia Lymphoma Oncology Organ Systems Treatment Of Cancer Tumor Adoptive Cell Transfer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags